ALX Oncology Holdings Inc.
ALXO
$2.14
-$0.06-2.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.65% | 27.89% | 34.14% | 13.57% | 35.87% |
| Total Depreciation and Amortization | -29.44% | -31.70% | -13.18% | -1.40% | 3.38% |
| Total Amortization of Deferred Charges | 4.35% | 9.09% | 4.55% | 4.69% | 7.81% |
| Total Other Non-Cash Items | -48.05% | -57.54% | -13.92% | -12.95% | 7.74% |
| Change in Net Operating Assets | 108.44% | 260.67% | -151.08% | 107.54% | -2,746.53% |
| Cash from Operations | 40.77% | 32.64% | 11.89% | 34.97% | 19.23% |
| Capital Expenditure | 18.33% | 62.42% | 47.78% | 59.46% | 59.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.06% | -17.00% | 2,143.03% | 4.07% | 301.25% |
| Cash from Investing | -66.15% | -16.74% | 2,360.42% | 4.43% | 299.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -768.42% | 55.31% | -8.72% | -75.43% | -20.63% |
| Issuance of Common Stock | -51.11% | -99.81% | -98.71% | -- | -99.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 266.57% | -100.00% | -100.00% | -87.70% | 108.16% |
| Cash from Financing | 106.71% | -163.35% | -100.82% | -97.89% | -99.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -582.53% | 628.87% | -187.88% | 136.43% | -48.09% |